These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2682676)

  • 1. Intestinal fat absorption and its relevance in lipid drug delivery systems.
    Eldem T; Speiser P
    Pharmazie; 1989 Jul; 44(7):444-7. PubMed ID: 2682676
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
    Porter CJ; Trevaskis NL; Charman WN
    Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coming of age of lipid-based drug delivery systems.
    Davis SS
    Adv Drug Deliv Rev; 2004 May; 56(9):1241-2. PubMed ID: 15109766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Absorption test of fat].
    Nakamura T
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():111-2. PubMed ID: 9172482
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased fat absorption and impaired fat clearance cause postprandial hypertriglyceridemia in Spontaneously Diabetic Torii rat.
    Sasase T; Morinaga H; Yamamoto H; Ogawa N; Matsui K; Miyajima K; Kawai T; Mera Y; Masuyama T; Shinohara M; Ohta T; Matsushita M
    Diabetes Res Clin Pract; 2007 Oct; 78(1):8-15. PubMed ID: 17448560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic drug delivery: an updated review.
    Shareef MA; Khar RK; Ahuja A; Ahmad FJ; Raghava S
    AAPS PharmSci; 2003; 5(2):E17. PubMed ID: 12866944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems.
    Subramanian N; Ghosal SK
    Indian J Exp Biol; 2004 Nov; 42(11):1056-65. PubMed ID: 15587110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
    Porter CJ; Wasan KM; Constantinides P
    Adv Drug Deliv Rev; 2008 Mar; 60(6):615-6. PubMed ID: 18160174
    [No Abstract]   [Full Text] [Related]  

  • 13. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes and skin: from drug delivery to model membranes.
    El Maghraby GM; Barry BW; Williams AC
    Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
    Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
    J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing oral absorption in animals.
    Crowley PJ; Martini LG
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):73-80. PubMed ID: 11727326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
    Pouton CW; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targeting using conjugates: the importance of pharmaceutical chemistry.
    Byrn SR; Stowell JG
    J Drug Target; 1995; 3(4):239-41. PubMed ID: 8820996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.